Download FREE Sample
Table of Contents
- Introduction
- Introduction
- Market Scope
- Market Definition
- Segments Covered
- Regional Segmentation
- Research Timeframe
- Currency Considered
- Study Limitations
- Stakeholders
- List of Abbreviations
- Key Conferences and Events (2023-2024)
- Research Methodology
- Secondary Research
- Primary Research
- Market Estimation
- Bottom-Up Approach
- Top-Down Approach
- Market Forecasting
- Executive Summary
- Alzheimer's Drug Market Snapshot (2023-2029)
- Segment Overview
- Regional Snapshot
- Competitive Insights
- MarRising investments in R&D by market players
- Growing cases of Alzheimer's and dementia
- Increasing awareness regarding Alzheimer's disease
- Restraints
- High failure rates of clinical studies
- Complex and lengthy regulatory approval process
- Opportunities
- Increasing government funding and initiatives
- Growth in healthcare expenditure
- Key Market Trends
- Use of biomarkers in Alzheimer's diagnosis
- Growing focus on personalized medicine
- Unmet Market Needs
- Industry Speaks
- Global Alzheimer's Drug Market Size & Forecast (2022-2029), By Drug Class, USD Million
- Introduction
- Cholinergic
- Donepezil
- Galantamine
- Rivastigmine
- NMDA Receptor Antagonist
- Combination Drug
- Pipeline Drugs
- Global Alzheimer's Drug Market Size & Forecast (2022-2029), By Application, USD Million
- Introduction
- Disease Progression
- Symptom Management
- Global Alzheimer's Drug Market Size & Forecast (2022-2029), By Distribution Channel, USD Million
- Introduction
- Hospital Pharmacies
- Retail Pharmacies & Drug Stores
- E-commerce
- Others
- Global Alzheimer's Drug Market Size & Forecast (2022-2029), By s Drug Market Size & Forecast (2022-2029), By Country, USD Million
- US
- Market Size & Forecast, By Drug Class (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By Distribution Channel (USD Million)
- Canada
- Market Size & Forecast, By Drug Class (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By Distribution Channel (USD Million)
- Alzheimer's Drug Market Size & Forecast (2022-2029), By Country, USD Million
- UK
- Market Size & Forecast, By Drug Class (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By Distribution Channel (USD Million)
- Germany
- Marketi>
- Market Size & Forecast, By Distribution Channel (USD Million)
- France
- Market Size & Forecast, By Drug Class (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By Distribution Channel (USD Million)
- Italy
- Market Size & Forecast, By Drug Class (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By Distribution Channel (USD Million)
- Spain
- Market Size & Forecast, By Drug Class (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By Distribution Channel (USD Million)
- Rest of Europe
- Market Size & Forecast, By Drug Class (USD Million)
- MaD Million)
- Asia Pacific (APAC) Alzheimer's Drug Market Size & Forecast (2022-2029), By Country, USD Million
- China
- Market Size & Forecast, By Drug Class (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By Distribution Channel (USD Million)
- Japan
- Market Size & Forecast, By Drug Class (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By Distribution Channel (USD Million)
- India
- Market Size & Forecast, By Drug Class (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By Distribution Channel (USD Million)
- Rest of Asia Pacific
- Market Size &aarket Size & Forecast, By Distribution Channel (USD Million)
- Latin America (LATAM) Alzheimer's Drug Market Size & Forecast (2022-2029), USD Million
- Market Size & Forecast, By Drug Class (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By Distribution Channel (USD Million)
- Middle East & Africa (MEA) Alzheimer's Drug Market Size & Forecast (2022-2029), USD Million
- Market Size & Forecast, By Drug Class (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By Distribution Channel (USD Million)
- Competitive Landscape
- Key Players and their Competitive Positioning
- Competitive Positioning of Key Players (2022)
- Offerings Assessment, By Player
- Key Strategies Assessment, By Player (2021-2023)
- New Product & Service Launches
- Partnerships, Agreements, & Collaborations
- Mergers & Acquisitions
- Geographic Expansion
- Key Players and their Competitive Positioning
- China
- UK
- US
- Key Companies Scanned (Indicative List)
- Eli Lily
- Johnson & Johnson
- Sanofi
- Novartis AG
- Biogen Inc.
- Eisai Co., Ltd.
- AbbVie Inc. (Allergan Plc.)
- Adamas Pharmaceuticals, Inc.
- Lundbeck A/S
- AC Immune
- Hoffmann La Roche Ltd.
- Daiichi Sankyo Company, Limited
- TauRx Pharmaceuticals Ltd.
- Other
